from THCB at http://bit.ly/2dxLxax on September 30, 2016 at 03:54PM By VARUN SETHI, MD Letters of recommendation (LORs) are a common part of the job application. Employers rely on them to help choose new hires. Many physicians have written reference letters for their peers and trainees. It is important to appreciate that LOR is a […]
from Health and Quality of Life Outcomes at http://bit.ly/2ddMN40 on September 30, 2016 at 03:39PM Initiation and titration of human regular U-500 insulin (U-500R) with a dosing algorithm of either thrice daily (TID) or twice daily (BID) improved glycemic control with fewer injections in patients with type …
from Health and Quality of Life Outcomes at http://bit.ly/2dCdnq4 on September 30, 2016 at 03:39PM Implantable cardioverter defibrillators (ICD) were developed for primary and secondary prevention of sudden cardiac death. However, ICD recipients’ mortality is significantly predicted by their quality of life…
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2dtgDzf on September 30, 2016 at 11:47AM The Institute for Clinical and Economic Review (ICER) recently released an Evidence Report assessing the comparative clinical effectiveness and value of treatments for non-small cell lung cancer (NSCLC). Find out more here. (Source: ICER, 9/29/16)
from Brookings: Topics – Health at http://brook.gs/2dxdY8w on September 30, 2016 at 11:46AM This book, part of Brookings’ Studies in Social Economics series, examines medical innovations and technology developments in American hospitals.
from The Incidental Economist at http://bit.ly/2cRbFPv on September 30, 2016 at 11:42AM People aren’t paying enough attention! This is Healthcare Triage News. For those of you who want to read more: Timing of Allergenic Food Introduction to the Infant Diet and Risk of Allergic or Autoimmune Disease: A Systematic Review and Meta-analysis Effect of Wearable […]
from Brookings: Topics – Health at http://brook.gs/2dxdY8w on September 30, 2016 at 11:23AM This book, part of Brookings’ Studies in Social Economics series, examines medical innovations and technology developments in American hospitals.
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2ddot5t on September 30, 2016 at 11:17AM The Institute for Clinical and Economic Review (ICER) recently released a Draft Evidence Report to assess the comparative clinical effectiveness and value of targeted immunomodulators for adults with moderate-to-severe plaque psoriasis. Read more here. (Source: ICER, 9/29/16)
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2cH41E5 on September 30, 2016 at 10:47AM The ISPOR Nominations Committee recently announced the call for nominees to serve on the 2017- 2018 Board of Directors. See more here on the nomination process and deadlines. (Source: ISPOR, 2016)
from The Incidental Economist at http://bit.ly/2cH0429 on September 30, 2016 at 10:19AM #6things That Happened in Health Policy This Week 6 Things That Happened in Health Policy This Week is produced by a mix of research assistants from the Healthcare Quality & Outcomes (HQO) Initiative at the Harvard T.H. Chan School of Public Health. In […]
from The European Journal of Health Economics at http://bit.ly/2dfiTgF on September 30, 2016 at 07:16AM Abstract Background Increasing health costs in developed countries are a major concern for decision makers. A variety of cost containment tools are used to control this trend, including maximum price regulation and reimbursement methods for health technologies. Information regarding expenditure-related […]
from Market Design at http://bit.ly/2dwDpqZ on September 30, 2016 at 06:49AM It’s a little hard to see, but the medal forms a saddle point: the intersection of the two lines is a maximum in the horizontal direction and a minimum in the vertical direction… It had been a long time since I thought of equilibrium […]
from Terry Flynn PhD at http://bit.ly/2d0LeEo on September 30, 2016 at 04:15AM Well well well. I have finally found something that qualifies both as a Friday Fun post and as something relevant to choice modelling – more potential Chinese problems with Likert scales! The number 4 is known to be considered unlucky in some more […]
from Google Alert at http://bit.ly/2dbL4fO on September 30, 2016 at 03:40AM It includes such diverse areas as health outcomes research, technology assessment, knowledge translation, health economics and economic …
from PILLECONOMICS at http://bit.ly/2cQ4mri on September 30, 2016 at 02:53AM Jaume Puig-Junoy, Santiago Rodríguez-Feijóo, Beatriz González López-Valcárcel, Vanessa Gómez-Navarro Rev Esp Salud Pública. Vol. 90: 29 de abril de 2016: e1-e14. http://www.msc.es/resp Fundamentos: El objetivo fue conocer si la reforma del copago farmacéutico español en 2012 ha afectado el consumo de los medicamentos para enfermedades […]
from Healthcare Economist at http://bit.ly/2drCWp0 on September 30, 2016 at 02:28AM Using biomarker data. Cancer moonshot has started. Frakt on value frameworks. A downside of work. Drug price negotiation coming to the U.S.
from Health Economics at http://bit.ly/2drzZor on September 30, 2016 at 02:06AM Abstract In this paper, we address the issue of whether it is economically advantageous to concentrate emergency rooms (ERs) in large hospitals. Besides identifying economies of scale of ERs, we also focus on chain economies. The latter term refers to the effects on a […]
from Journal of Health Economics at http://bit.ly/2cFBbc5 on September 30, 2016 at 01:24AM Publication date: Source:Journal of Health Economics Author(s): Susan L. Ettner, Jessica Harwood, Amber Thalmayer, Michael K. Ong, Haiyong Xu, Michael J. Bresolin, Kenneth B. Wells, Chi-Hong Tseng, Francisca Azocar
from Terry Flynn PhD at http://bit.ly/2dw8uLj on September 30, 2016 at 01:14AM Interesting article here about the casualisation of work in universities. It, perhaps, gives additional insights into my move into industry. Now, I’m not going to claim I was treated like the case study in the article for a minute. However, I’ve seen which […]
from Google Alert at http://bit.ly/2dvpiXh on September 29, 2016 at 06:39PM Alnylam focus: The core purpose of Health Economics and Outcomes Research (HEOR) at Alnylam is to lead evidence generation and value …
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2dbmFu6 on September 29, 2016 at 06:04PM Can you match your co-workers with the people in this meeting? Watch here. (Source: Tripp and Tyler, YouTube, 11/5/14)
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2deOKfN on September 29, 2016 at 05:02PM Improving the care of high-need, high-cost (HNHC) patients is a compelling national challenge and should be a high priority for the next federal administration. A variety of promising policy options can promote improved care for HNHC patients. Some can be accomplished through […]
from THCB at http://bit.ly/2dhE5S1 on September 29, 2016 at 03:12PM By JEFF GOLDSMITH and LAWTON BURNS In the world of fine wine, it is well known that some types of wine grapes grow only in very specific climates and ecologies. The concept borrowed from the French is “terroir” (ter-WAHR). Terroir explains why the finest champagne […]
from Health Economics Review at http://bit.ly/2dohOUf on September 29, 2016 at 02:30PM The aim of this study was to compare post-authorisation measures (PAMs) from the European Medicines Agency (EMA) with data requests in fixed-termed conditional appraisals of early benefit assessments from the …
from Health Care Policy and Marketplace … at http://bit.ly/2dhw4MK on September 29, 2016 at 01:47PM Amy Goldstein at the Washington Post is out with a story reporting that the Obama administration is looking to use an obscure federal law to pay billions of dollars in Obamacare risk corridor liabilities to participating insurance companies. You might […]
from Brookings: Topics – Health at http://brook.gs/2duPsEX on September 29, 2016 at 12:56PM A growing body of research indicates that prevention offers the promise of better ways to maintain health and extend life. In this timely volume, Louise B. Russell shows that preventive measures are not as simple as often depicted—while many do improve health, […]
from Brookings: Topics – Health at http://brook.gs/2duPsEX on September 29, 2016 at 12:31PM A growing body of research indicates that prevention offers the promise of better ways to maintain health and extend life. In this timely volume, Louise B. Russell shows that preventive measures are not as simple as often depicted—while many do improve health, […]
from Brookings: Topics – Health at http://brook.gs/2dHlu3W on September 29, 2016 at 11:01AM This collection of six papers on the role of quantitative risk assessment in the promulgation of recent regulatory standards represents the latest contribution to a series of volumes published by Lester Lave and the Brookings Institution on regulatory decisionmaking.
from Brookings: Topics – Health at http://brook.gs/2dHlu3W on September 29, 2016 at 10:55AM This collection of six papers on the role of quantitative risk assessment in the promulgation of recent regulatory standards represents the latest contribution to a series of volumes published by Lester Lave and the Brookings Institution on regulatory decisionmaking.
from Brookings: Topics – Health at http://brook.gs/2d8NI63 on September 29, 2016 at 10:55AM Among various health cost containment strategies proposed during the 1970s, none has held more sustained fascination than the health maintenance organization (HMO). For many years, policy analysts in search of market- and incentive-based alternatives to “command and control” regulation have argued that […]
from Econsalut at http://bit.ly/2d8Rkol on September 29, 2016 at 10:49AM Departures from Cost-Effectiveness Recommendations: The Impact of Health System Constraints on Priority Setting Cost-effectiveness may be considered a focal point for health economists. However the… [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
from Brookings: Topics – Health at http://brook.gs/2d8NI63 on September 29, 2016 at 10:31AM Among various health cost containment strategies proposed during the 1970s, none has held more sustained fascination than the health maintenance organization (HMO). For many years, policy analysts in search of market- and incentive-based alternatives to “command and control” regulation have argued that […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2doKZmw on September 29, 2016 at 08:59AM Cancer care’s increasing costs in the United States have received a lot of attention lately, but when is the right time to discuss affordability vs effectiveness? Should clinicians discuss this with patients as part of their decision-making procedures? Read more here. […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2dx8yhK on September 29, 2016 at 08:29AM The Center for American Progress recently outlined a framework to establish a negotiation process for Medicare and private health care payers and incorporates comparative effectiveness research (CER). Learn more here. (Source: Topher Spiro, Maura Calsyn, Thomas Huelskoetter, Center for American Progress, 9/26/16)
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2d8kzYE on September 29, 2016 at 07:58AM Mylan CEO, Heather Bresch, recently testified under oath about the company’s profits on their emergency allergy treatment, EpiPen. However, a recent report shows the company actually makes 60% more than they disclosed to Congress. Find out how the company lied about […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2cNKHbv on September 29, 2016 at 07:28AM Nominations are now being accepted for the AMCP Awards Program. This is your opportunity to nominate your peers or yourself for outstanding contributions to the Academy. The following awards are accepting nominations: Distinguished Service Award Individual Contribution Award JMCP Award of […]
from Market Design at http://bit.ly/2dn87oV on September 29, 2016 at 06:59AM The long story of whether some forms of blood stem cell (marrow) donation may be compensated seems to be coming to an end, back where it began. Here’s the new HHS/HRSA regulation, saying that whether as marrow or in the blood stream, these are […]
from OHE News at http://bit.ly/2dtI64E on September 29, 2016 at 06:19AM 2016 Annual Lecture with Dame Sally Davies: 10 Years of NIHR: Achievements and Challenges for the Next Decade Thursday, 29 September 2016 OHE’s annual lecture 2016 will be held on Monday 7 November at the Royal College of Physicians, London. The lecture will be […]
from The European Journal of Health Economics at http://bit.ly/2dlyOHg on September 29, 2016 at 06:09AM Abstract Since 1999, Polish health policy has changed, the quality of services has increased, and also the level of financing, mainly from public benefits. Despite constant growth of indexes reflecting the health status of Polish society, such as life expectancy, […]
from feed/http://bit.ly/1sYYZLQ at http://bit.ly/2dtI64E on September 29, 2016 at 04:52AM 2016 Annual Lecture with Dame Sally Davies: 10 Years of NIHR: Achievements and Challenges for the Next Decade Thursday, 29 September 2016 OHE’s annual lecture 2016 will be held on Monday 7 November at the Royal College of Physicians, London. The lecture will be given […]
Health Econ Bot 
You must be logged in to post a comment.